Published in Pancreas on January 01, 2014
An unusual phenotype of MEN1 syndrome with a SI-NEN associated with a deletion of the MEN1 gene. Endocrinol Diabetes Metab Case Rep (2016) 0.75
Mouse Models Recapitulating Human Adrenocortical Tumors: What Is Lacking? Front Endocrinol (Lausanne) (2016) 0.75
Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med (2008) 9.20
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93
The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg (2009) 5.33
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res (2008) 4.35
Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology (2008) 4.03
Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology (2007) 3.85
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology (2011) 2.66
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol (2009) 2.42
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology (2013) 2.42
Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol (2011) 2.39
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology (2006) 2.32
Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers. J Hepatol (2008) 2.22
Lung dendritic cells induce migration of protective T cells to the gastrointestinal tract. J Exp Med (2013) 1.99
Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol (2007) 1.95
NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas (2010) 1.90
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol (2008) 1.84
MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. Gastroenterology (2011) 1.77
Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg (2012) 1.70
Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas (2013) 1.65
Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg (2015) 1.53
The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum. Pancreas (2010) 1.51
Surgery in malignant pancreatic neuroendocrine tumors. J Surg Oncol (2007) 1.51
Case report: lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol (2006) 1.50
Laparoscopic antrectomy for the treatment of type I gastric carcinoid tumors. J Surg Res (2010) 1.47
Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis (2011) 1.46
De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci (2006) 1.45
Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg (2004) 1.36
BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer. Cancer (2014) 1.32
Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature. Dig Dis Sci (2010) 1.25
Dissecting EASL/AASLD Recommendations With a More Careful Knife: A Comment on "Surgical Misinterpretation" of the BCLC Staging System. Ann Surg (2015) 1.17
Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease. Clin Transplant (2004) 1.17
Feasibility and preliminary accuracy of high-resolution imaging of the liver and pancreas using FNA compatible microendoscopy (with video). Gastrointest Endosc (2012) 1.09
Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery (2007) 1.07
Morphologic features of extrahepatic manifestations of hepatitis C virus infection. Clin Dev Immunol (2012) 1.04
Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection. J Hepatobiliary Pancreat Surg (2002) 1.03
T cell–derived inducible nitric oxide synthase switches off Th17 cell differentiation. J Exp Med (2013) 1.03
Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl (2009) 1.02
Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg (2008) 1.02
Histologic characteristics of pancreatic intraepithelial neoplasia associated with different pancreatic lesions. Hum Pathol (2010) 0.99
Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Ann Surg (2014) 0.99
Presentation, treatment, and outcome of type 1 gastric carcinoid tumors. J Surg Oncol (2006) 0.97
How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated? J Hepatol (2005) 0.97
Clinical and prognostic features of rectal neuroendocrine tumors. Neuroendocrinology (2013) 0.96
Liver transplantation for neuroendocrine tumors. J Gastrointest Surg (2004) 0.93
Primary Ewing sarcoma/PNET of the kidney: fine-needle aspiration, histology, and dual color break apart FISH Assay. Diagn Cytopathol (2007) 0.92
Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction. Semin Liver Dis (2011) 0.91
Recurrence of hepatocellular carcinoma after liver transplantation: is immunosuppression a factor? Liver Transpl (2005) 0.90
Epstein-Barr virus-associated smooth muscle tumors in children following solid organ transplantation: a review. Pediatr Transplant (2015) 0.88
The role of Ki-67 in predicting biological behavior of goblet cell carcinoid tumor in appendix. Am J Surg (2011) 0.88
Multifocal hepatocellular carcinoma and precancerous lesions in a patient with autoimmune hepatitis-related cirrhosis. Semin Liver Dis (2008) 0.88
Resection of hepatocellular carcinoma without cirrhosis. Ann Surg (2012) 0.87
Early and late results of valvular surgery for carcinoid heart disease. J Am Coll Cardiol (2008) 0.86
Testicular metastasis of primary cecal carcinoid tumor. Ann Diagn Pathol (2004) 0.86
Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT). Abdom Imaging (2011) 0.86
Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol (2008) 0.86
Retracted Liver functional reserve estimation: state of the art and relevance to local treatments. Oncology (2010) 0.86
Giant hemangioma of the adrenal. Isr Med Assoc J (2004) 0.85
In vitro chemoresistance testing in well-differentiated carcinoid tumors. Ann Surg Oncol (2009) 0.85
Actual 10-year survival following hepatectomy for hepatocellular carcinoma. HPB (Oxford) (2013) 0.84
Biochemical assessment of niacin deficiency among carcinoid cancer patients. Am J Gastroenterol (2005) 0.84
A recombinant murine meizothrombin precursor, prothrombin R157A/R268A, inhibits thrombosis in a model of acute carotid artery injury. Blood (2004) 0.84
The risk of metachronous cancers in patients with small-intestinal carcinoid tumors: a US population-based study. Endocr Relat Cancer (2012) 0.84
Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors. J Clin Oncol (2013) 0.84
Carcinoma ex microcystic adenoma of the pancreas: a report of a novel form of malignancy in serous neoplasms. Am J Surg Pathol (2012) 0.83
Atypical lung carcinoid metastasis to breast: a case report. Pancreas (2011) 0.83
Protein-losing enteropathy in ulcerative colitis. Case Rep Gastroenterol (2012) 0.83
Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation (2005) 0.83
Liver functional reserve estimation: state of the art and relevance for local treatments: the Western perspective. J Hepatobiliary Pancreat Sci (2009) 0.83
Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumors. Pancreas (2011) 0.82
Tubular carcinoid tumor: a rare cause of appendicitis. Am Surg (2009) 0.82
Management of goblet cell carcinoid. J Surg Oncol (2006) 0.82
Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome. Liver Transpl (2005) 0.82
Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal. Liver Transpl (2006) 0.82
Serum pancreastatin: the next predictive neuroendocrine tumor marker. J Surg Oncol (2013) 0.82
Early bioprosthetic valve deterioration after carcinoid plaque deposition. Ann Thorac Surg (2009) 0.81
The role of fibrin sealants in hepatic surgery. Surg Technol Int (2007) 0.81
The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer. Int J Gynecol Cancer (2014) 0.81
Diaphragmatic hernia after hepatic resection: case series at a single Western institution. J Gastrointest Surg (2012) 0.81
Outcomes following resection of intrahepatic cholangiocarcinoma. HPB (Oxford) (2014) 0.81
Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors. Neuroendocrinology (2015) 0.79
Clinical research in hepatocellular carcinoma: study design and endpoints. J Hepatol (2009) 0.79
FDG PET/CT imaging to rule out extrahepatic metastases before liver transplantation. Clin Nucl Med (2007) 0.79
Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis. J Am Coll Surg (2003) 0.78
Hormonal and nutritional regulation of muscle carnitine palmitoyltransferase I gene expression in vivo. Arch Biochem Biophys (2007) 0.78
Surgical resection for advanced gallbladder carcinoma. The Mount Sinai experience. Hepatogastroenterology (2011) 0.78
Advanced EUS imaging for early detection of pancreatic cancer. Gastrointest Endosc Clin N Am (2013) 0.78
Hepatocellular carcinoma in chronic hepatitis C in the absence of advanced fibrosis or cirrhosis. AJR Am J Roentgenol (2013) 0.77
Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis. HPB (Oxford) (2012) 0.77
Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience. Dig Dis Sci (2014) 0.77
Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol (2013) 0.77
Laparoscopic resection of a schwannoma of the ascending colon. Am Surg (2010) 0.77
Multiple inflammatory and serum amyloid A positive telangiectatic hepatic adenomas with glycogenated nuclei arising in a background of nonalcoholic steatohepatitis. Semin Liver Dis (2008) 0.77
The clinical utility of Ki-67 in assessing tumor biology and aggressiveness in patients with appendiceal carcinoids. J Surg Oncol (2010) 0.77